Janssen CarePath is becoming J&J withMe. Our name may be changing, but our commitment to patients stays the same. Learn more
Janssen CarePath is becoming J&J withMe. During this transition, you may see both program names in use.
At Johnson & Johnson, we are committed to helping people live fuller lives. Our J&J withMe program is here at every step to provide personalized support to help patients start and stay on their J&J medicines.
When it comes to getting the treatment you need, we want to help you find ways to lower your out-of-pocket costs. Whether you have commercial insurance or government-based coverage—or even no insurance at all—we can help you find the programs you may need to help you pay for Infliximab.
*Savings Program for patients with commercial or private insurance coverage.
Eligible patients using commercial or private insurance can save on out-of-pocket medication costs for Infliximab. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Eligible patients pay $5 for each infusion, with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give you your infusion.
We provide cost support directly to patients through the Janssen CarePath Savings Program. This benefit is intended to help eligible patients afford their out-of-pocket obligations as set by their health plans. The cost support is meant solely for patients—not health plans and/or their partners. If you are having any difficulty accessing cost support through the Janssen CarePath Savings Program, please contact us at 877-CarePath (877-227-3728).
To determine if you are eligible for Janssen CarePath Savings Program and get a Savings Program card, if you don’t have one:
Getting a rebate:
How to submit a rebate request:
Or call a Janssen CarePath Case Manager at 877-CarePath (877-227-3728) for help getting started.
Some states sponsor prescription financial assistance programs, each with its own eligibility requirements. Find out if your state has a program that can help you.
Independent co-pay assistance foundations have their own rules for eligibility, which are subject to change. We cannot guarantee a foundation will help you. We can only refer you to foundations that support your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. The foundations on this list are not the only ones that might be able to help you.
Patient assistance is available if you have commercial, employer-sponsored, or government coverage that does not fully meet your needs. You may be eligible to receive your Janssen medication free of charge for up to one year. You must meet the eligibility and income requirements for the Janssen Patient Assistance Program. See terms and conditions at PatientAssistanceInfo.com or call 833-742-0791.
Some states sponsor prescription financial assistance programs, each with its own eligibility requirements. Find out if your state has a program that can help you.
Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance . Find out if your state has a program that can help you.
Medicaid and the Children's Health Insurance Program (CHIP) provide free or low-cost health coverage to millions of Americans, including some low-income people, families and children, pregnant women, the elderly, and people with disabilities.
Some states have expanded their Medicaid programs to cover all people below certain income levels.
Independent co-pay assistance foundations have their own rules for eligibility, which are subject to change. We cannot guarantee a foundation will help you. We can only refer you to foundations that support your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. The foundations on this list are not the only ones that might be able to help you.
Patient assistance is available if you have commercial, employer-sponsored, or government coverage that does not fully meet your needs. You may be eligible to receive your Janssen medication free of charge for up to one year. You must meet the eligibility and income requirements for the Janssen Patient Assistance Program. See terms and conditions at PatientAssistanceInfo.com or call 833-742-0791.
Some states sponsor prescription financial assistance programs, each with its own eligibility requirements. Find out if your state has a program that can help you.
Medicaid and the Children's Health Insurance Program (CHIP) provide free or low-cost health coverage to millions of Americans, including some low-income people, families and children, pregnant women, the elderly, and people with disabilities.
Some states have expanded their Medicaid programs to cover all people below certain income levels.
Check the Health Insurance Marketplace at Healthcare.gov to see if you can enroll in a plan.
Independent co-pay assistance foundations have their own rules for eligibility, which are subject to change. We cannot guarantee a foundation will help you. We can only refer you to foundations that support your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. The foundations on this list are not the only ones that might be able to help you.
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson companies. You may be eligible if you don't have insurance.
Want to see if you qualify? Get an application at JJPAF.org.
Questions? Call 800-652-6227 ( Monday through Friday , 8:00 AM to 8:00 PM ET ).
Eligible patients using commercial or private insurance can save on out-of-pocket medication costs for Infliximab. Depending on your health insurance plan, savings may apply toward co-pay, co-insurance, or deductible. Eligible patients pay $5 for each infusion, with a $20,000 maximum program benefit per calendar year. Not valid for patients using Medicare, Medicaid, or other government-funded programs to pay for their medications. Terms expire at the end of each calendar year and may change. There is no income requirement. Program does not cover the cost to give you your infusion.
We provide cost support directly to patients through the Janssen CarePath Savings Program. This benefit is intended to help eligible patients afford their out-of-pocket obligations as set by their health plans. The cost support is meant solely for patients—not health plans and/or their partners. If you are having any difficulty accessing cost support through the Janssen CarePath Savings Program, please contact us at 877-CarePath (877-227-3728).
To determine if you are eligible for Janssen CarePath Savings Program and get a Savings Program card, if you don’t have one:
Getting a rebate:
How to submit a rebate request:
Or call a Janssen CarePath Case Manager at 877-CarePath (877-227-3728) for help getting started.
Some states sponsor prescription financial assistance programs, each with its own eligibility requirements. Find out if your state has a program that can help you.
Many states have programs for people with limited income and resources that pay some or all of Medicare's premiums and may pay Medicare deductibles and co-insurance . Find out if your state has a program that can help you.
Medicaid and the Children's Health Insurance Program (CHIP) provide free or low-cost health coverage to millions of Americans, including some low-income people, families and children, pregnant women, the elderly, and people with disabilities.
Some states have expanded their Medicaid programs to cover all people below certain income levels.
Check the Health Insurance Marketplace at Healthcare.gov to see if you can enroll in a plan.
Independent co-pay assistance foundations have their own rules for eligibility, which are subject to change. We cannot guarantee a foundation will help you. We can only refer you to foundations that support your disease state. This information is provided as a resource for you. We do not endorse any particular foundation. The foundations on this list are not the only ones that might be able to help you.
Patient assistance is available if you have commercial, employer-sponsored, or government coverage that does not fully meet your needs. You may be eligible to receive your Janssen medication free of charge for up to one year. You must meet the eligibility and income requirements for the Janssen Patient Assistance Program. See terms and conditions at PatientAssistanceInfo.com or call 833-742-0791.
The Johnson & Johnson Patient Assistance Foundation, Inc. (JJPAF) is an independent, nonprofit organization. JJPAF gives eligible patients free prescription medicines donated by Johnson & Johnson companies. You may be eligible if you don't have insurance.
Want to see if you qualify? Get an application at JJPAF.org.
Questions? Call 800-652-6227 ( Monday through Friday , 8:00 AM to 8:00 PM ET ).
Be sure to contact the programs directly to get details on eligibility and application requirements, and to see if they may be able to help you.
To view programs that are best suited for you, select your coverage status for INFLIXIMABInfliximab is a prescription medication used to treat:
Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in adult patients with moderately to severely active Crohn’s disease who haven't responded well to other therapies
Pediatric Crohn's Disease
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active Crohn's disease who haven't responded well to other therapies
Ulcerative Colitis
Can reduce signs and symptoms, induce and maintain remission, promote intestinal healing, and reduce or stop the need for steroids in adult patients with moderately to severely active ulcerative colitis who haven't responded well to other therapies
Pediatric Ulcerative Colitis
Can reduce signs and symptoms and induce and maintain remission in children (ages 6-17) with moderately to severely active ulcerative colitis who haven’t responded well to other therapies
Rheumatoid Arthritis
Can reduce signs and symptoms, help stop further joint damage, and improve physical function in adult patients with moderately to severely active rheumatoid arthritis, in combination with methotrexate
Psoriatic Arthritis
Can reduce signs and symptoms of active arthritis, help stop further joint damage, and improve physical function in adult patients with psoriatic arthritis
Ankylosing Spondylitis
Can reduce signs and symptoms in adult patients with active ankylosing spondylitis
Plaque Psoriasis
Approved for the treatment of adult patients with chronic severe (extensive and/or disabling) plaque psoriasis under the care of a physician who will determine if Infliximab is appropriate considering other available therapies
IMPORTANT SAFETY INFORMATION
Only your doctor can recommend a course of treatment after checking your health condition. Infliximab can cause serious side effects such as lowering your ability to fight infections. Some patients, especially those 65 years and older, have had serious infections which include tuberculosis (TB) and infections caused by viruses, fungi, or bacteria that have spread throughout the body or caused infections in certain areas (such as skin). Some of these infections have been fatal. Your doctor should monitor you closely for signs and symptoms of TB during treatment with Infliximab.
Unusual cancers have been reported in children and teenage patients taking tumor necrosis factor (TNF) blocker medicines. Hepatosplenic T-cell lymphoma, a rare form of fatal lymphoma, has occurred mostly in male teenagers or young men with Crohn’s disease or ulcerative colitis who were taking Infliximab and azathioprine or 6-mercaptopurine. For children and adults taking TNF blockers, including Infliximab, the chances of getting lymphoma or other cancers may increase. You should discuss any concerns about your health and medical care with your doctor.
It is not known if Infliximab is safe and effective in children under 6 years of age.
What should I tell my doctor before I take Infliximab?
You should let your doctor know if you have or ever had any of the following:
Also tell your doctor if you:
What should I watch for and talk to my doctor about before or while taking Infliximab?
The following serious (sometimes fatal) side effects have been reported in people taking Infliximab.
You should tell your doctor right away if you have any of the signs listed below:
The more common side effects of Infliximab include respiratory infections (such as sinus infections and sore throat), headache, coughing and stomach pain.
Please read the full Prescribing Information, including Boxed Warning, and Medication Guide for Infliximab and discuss any questions you have with your doctor.